Cargando…
Carcinoembryonic antigen in pleural effusion of patients with lung adenocarcinoma: a predictive marker for EGFR mutation
BACKGROUND: Carcinoembryonic antigen (CEA) can reflect tumor growth, recurrence and metastasis, and also predict the clinical efficacy of the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). In the present study, we investigated the association between CEA in serum and pleural...
Autores principales: | Lv, Yan-Ling, Liu, Hong-Bing, Yuan, Dong-Mei, Zhou, Li, Jin, Shu-Xian, Song, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797982/ https://www.ncbi.nlm.nih.gov/pubmed/35116846 http://dx.doi.org/10.21037/tcr.2019.06.10 |
Ejemplares similares
-
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion
por: Hackner, Klaus, et al.
Publicado: (2019) -
Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
por: Krishnan, Vishnu G, et al.
Publicado: (2021) -
Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
por: Salama, G., et al.
Publicado: (1998) -
EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
por: Smits, Alexander J. J., et al.
Publicado: (2012) -
EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
por: Yang, Jiyoul, et al.
Publicado: (2018)